Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Low ability to service debt as the company has a high Debt to EBITDA ratio of -1.00 times
The company has declared Negative results for the last 5 consecutive quarters
Risky - Negative EBITDA
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Software Products
USD 56 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
5.44
-4,712.02%
56.39
Total Returns (Price + Dividend) 
SurgePays, Inc. for the last several years.
Risk Adjusted Returns v/s 
News

SurgePays, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Financial Metrics
SurgePays, Inc. reported its highest operating profit for the quarter ending June 2025, despite a significant decline in net sales and operating cash flow. The company faces challenges with a low return on capital employed and a high debt-equity ratio, while its stock has outperformed the S&P 500 over the past year.
Read MoreIs SurgePays, Inc. technically bullish or bearish?
As of 2 September 2025, the technical trend for SurgePays, Inc. has changed from sideways to mildly bullish. The daily moving averages indicate a bullish stance, while the weekly MACD and KST show a mildly bearish signal, contrasting with the monthly indicators which are mildly bullish. The Bollinger Bands suggest a bullish trend on both weekly and monthly time frames. Overall, the technical stance is mildly bullish, driven primarily by the daily moving averages and the monthly Bollinger Bands. In terms of performance, SurgePays has significantly outperformed the S&P 500 over the past month with a return of 26.87% compared to the S&P 500's 2.33%, and it has also shown strong returns year-to-date at 61.80% versus 12.22% for the index....
Read MoreIs SurgePays, Inc. overvalued or undervalued?
As of 13 August 2024, SurgePays, Inc. has moved from a fair to a risky valuation grade. The company appears to be overvalued given its significant negative financial metrics, including a Price to Book Value of 7.32, an EV to EBIT of -1.09, and an EV to EBITDA of -1.12. Comparatively, peers such as Spire Global, Inc. and Fathom Holdings, Inc. also carry risky valuations with EV to EBITDA ratios of -8.2383 and -5.8220, respectively, indicating a challenging environment for the sector. Despite a strong year-to-date stock return of 61.80% compared to the S&P 500's 12.22%, the long-term performance shows a concerning trend, with a 3-year return of -42.05% versus the S&P 500's 70.41%. This disparity suggests that while recent performance may seem promising, the underlying financial health of SurgePays, Inc. raises significant concerns about its valuation....
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Domestic Funds
Held in 9 Schemes (4.67%)
Held by 18 Foreign Institutions (3.91%)
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
QoQ Growth in quarter ended Jun 2025 is 8.49% vs 10.42% in Mar 2025
QoQ Growth in quarter ended Jun 2025 is 6.58% vs 62.00% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -55.58% vs 12.84% in Dec 2023
YoY Growth in year ended Dec 2024 is -322.82% vs 3,533.33% in Dec 2023






